Active Ingredient: CASPOFUNGIN ACETATE
Proprietary Name: CASPOFUNGIN ACETATE
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 50MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A205923
Product Number: 001
Approval Date: Jul 2, 2018
Applicant Holder Full Name: XELLIA PHARMACEUTICALS APS
Marketing Status:
Discontinued
Patent and Exclusivity Information
